Skip to main content

Table 4 Frequencies of chemotherapy-related acute toxicities among the patients

From: Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy

Toxicity

Grade 0, n (%)

Grade 1, n (%)

Grade 2, n (%)

Grade 3, n (%)

Grade 4, n (%)

Induction chemotherapy (n = 41)

 Leukopenia

12 (29.3)

7 (17.1)

15 (36.6)

6 (14.6)

1 (2.4)

 Anemia

38 (92.7)

2 (4.9)

1 (2.4)

0

0

 Thrombocytopenia

37 (90.2)

2 (4.9)

2 (4.9)

0

0

 Liver dysfunction

41 (100)

0

0

0

0

 Renal dysfunction

41 (100)

0

0

0

0

Adjuvant chemotherapy (n = 33)

 Leukopenia

9 (27.3)

5 (15.2)

5 (15.2)

9 (27.3)

5 (15.2)

 Anemia

29 (87.9)

4 (12.1)

0

0

0

 Thrombocytopenia

31 (93.9)

2 (6.1)

0

0

0

 Liver dysfunction

33 (100)

0

0

0

0

 Renal dysfunction

32 (97.0)

1 (3.0)

0

0

0

  1. No radiotherapy-related late neurological toxicities, such as cranial nerve palsy, temporal lobe necrosis, brain stem injury, or spinal cord injury, were observed